Osteonecrosis is defined as “necrosis of bone due to obstruction of its blood supply” [1]. Although osteonecrosis of the jaw (ONJ) can be occur spontaneous or idiopathic, etiologic agents most often serve as modifiers for a specific case of ONJ. ONJ can result from radiation therapy to the head and neck, chronic corticosteroid use, herpes zoster virus infection in immunocompromised patients, anti-angiogenesis medications, uncontrolled infections or major trauma, and antiresorptive medication
Introduction The use of antiresorptive drugs concerns many medical specialties either in relation to...
Osteonecrosis of the jaws (ONJ) is an adverse side event of bisphosphonates and denosumab, antiresor...
Abstract Introduction Osteonecrosis of the jaws can result either from radiation, used in radiother...
Antiresorptive therapy significantly reduces fracture risk in patients with benign bone disease and ...
Osteonecrosis of the jaw (ONJ) is a rare adverse event of antiresorptive drugs such as bisphosphonat...
Medication-related osteonecrosis of the jaw is a recent pathology, initially mentioned in 2003 by Ma...
Medication-related osteonecrosis of the jaw is a known side-effect of antiresorptive therapy in pati...
Medication-related osteonecrosis of the jaw is a known side-effect of antiresorptive therapy in pati...
Osteonecrosis of the jaw (ONJ) is a serious complication of both radiation and antiresorptive therap...
Antiresorptive medications have proven to be extremely efficacious in the treatment of disorders of ...
This work provides a systematic review of the literature from January 2003 to April 2014 pertaining ...
Osteonecrosis of the jaws (ONJ) is an adverse side event of bisphosphonates and denosumab, antireso...
Osteonecrosis of the jaws (ONJ) is an adverse side event of bisphosphonates and denosumab, antiresor...
peer reviewedA potential side effect associated with bisphosphonates, a class of drugs used in the t...
Osteonecrosis of the jaws (ONJ) is an uncommon but severe bone disease, can be related to various me...
Introduction The use of antiresorptive drugs concerns many medical specialties either in relation to...
Osteonecrosis of the jaws (ONJ) is an adverse side event of bisphosphonates and denosumab, antiresor...
Abstract Introduction Osteonecrosis of the jaws can result either from radiation, used in radiother...
Antiresorptive therapy significantly reduces fracture risk in patients with benign bone disease and ...
Osteonecrosis of the jaw (ONJ) is a rare adverse event of antiresorptive drugs such as bisphosphonat...
Medication-related osteonecrosis of the jaw is a recent pathology, initially mentioned in 2003 by Ma...
Medication-related osteonecrosis of the jaw is a known side-effect of antiresorptive therapy in pati...
Medication-related osteonecrosis of the jaw is a known side-effect of antiresorptive therapy in pati...
Osteonecrosis of the jaw (ONJ) is a serious complication of both radiation and antiresorptive therap...
Antiresorptive medications have proven to be extremely efficacious in the treatment of disorders of ...
This work provides a systematic review of the literature from January 2003 to April 2014 pertaining ...
Osteonecrosis of the jaws (ONJ) is an adverse side event of bisphosphonates and denosumab, antireso...
Osteonecrosis of the jaws (ONJ) is an adverse side event of bisphosphonates and denosumab, antiresor...
peer reviewedA potential side effect associated with bisphosphonates, a class of drugs used in the t...
Osteonecrosis of the jaws (ONJ) is an uncommon but severe bone disease, can be related to various me...
Introduction The use of antiresorptive drugs concerns many medical specialties either in relation to...
Osteonecrosis of the jaws (ONJ) is an adverse side event of bisphosphonates and denosumab, antiresor...
Abstract Introduction Osteonecrosis of the jaws can result either from radiation, used in radiother...